Estimated excess of current replacement cost over LIFO cost of inventories

Medline, Inc. Estimated excess of current replacement cost over LIFO cost of inventories increased by 8.1% to $388.00M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement

SectionOther

CategoryRisk

SignalContext dependent

VolatilityVolatile

First reportedQ4 2014

Last reportedQ1 2026

How to read this metric

A larger gap indicates significant unrealized gains or potential tax liabilities if inventory levels are reduced.

Detailed definition

This represents the difference between the current market replacement cost of inventory and the value reported under the...

Peer comparison

Used by analysts to normalize earnings for companies using LIFO accounting.

Metric ID: other_excess_of_replacement_or_current_costs_over_stated_d85332

Historical Data

2 periods

	Q4 '25	Q1 '26
Value	$359.00M	$388.00M
QoQ Change	—	+8.1%

Range$359.00M – $388.00M

Frequently Asked Questions

What is Medline, Inc. 's estimated excess of current replacement cost over lifo cost of inventories?: Medline, Inc. (MDLN) reported estimated excess of current replacement cost over lifo cost of inventories of $388.00M in Q1 2026.
What does estimated excess of current replacement cost over lifo cost of inventories mean?: The difference between current market prices for inventory and the historical LIFO book value.